Press Release

March 18, 2019: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to provide shareholders with the year end financials and a corporate update. Year End Viridium has now filed the year end consolidated financial statements and management discussion and analysis for...

March 7, 2019: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), a licensed cultivation and processor under the Cannabis Act, has commenced clone sales as starting materials.  Its first...

VANCOUVER, BC / ACCESSWIRE / March 7, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (VIR.V) (VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. ("Experion"), a licensed cultivation and processor under the Cannabis Act, has commenced clone sales as...

February 21 2019,: Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. (“Experion”), a licensed cultivation and processor under the Cannabis Act, has completed its first shipment of Adult-Use cannabis to...

VANCOUVER, BC / ACCESSWIRE / February 21, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (VIR.V) (OTC PINK: VIRFF) is pleased to announce its wholly owned subsidiary, Experion Biotechnologies Inc. ("Experion"), a licensed cultivation and processor under the Cannabis Act, has completed its...

February 14, 2019: Experion Biotechnologies, a licensed cultivation and processor under the Cannabis Act and a wholly owned subsidiary of Viridium Pacific Group Ltd. (“Viridium” or the “Company”) (TSXV: VIR) (OTCPink: VIRFF) is pleased to announce it signed a supply agreement with the British Columbia...